Production (Stage)
CG Oncology, Inc.
CGON
$25.46
-$0.40-1.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.45M | -31.80M | -20.41M | -18.90M | -16.93M |
| Total Depreciation and Amortization | 24.00K | 0.00 | 21.00K | 7.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.68M | 6.24M | 1.06M | -230.00K | -685.00K |
| Change in Net Operating Assets | 469.00K | 4.90M | 3.40M | 3.01M | -8.40M |
| Cash from Operations | -29.28M | -20.66M | -15.92M | -16.12M | -26.01M |
| Capital Expenditure | -16.00K | -209.00K | 1.00K | -14.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -186.75M | 11.11M | 32.00M | -36.22M | -307.43M |
| Cash from Investing | -186.77M | 10.91M | 32.01M | -36.23M | -307.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -365.00K |
| Issuance of Common Stock | 682.00K | 223.41M | 2.17M | 77.00K | 406.41M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -232.00K | 0.00 | 0.00 | -37.00K | -3.39M |
| Cash from Financing | 450.00K | 223.41M | 2.17M | 40.00K | 402.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -215.60M | 213.66M | 18.25M | -52.31M | 69.20M |